Skin problems can often be ignored as simple rashes or breakouts. But sometimes an itchy patch or the random blisters may ...

Recent FDA decisions added new options for dermatologists involved in treating patients with psoriasis, bullous pemphigoid ...

U.K. adults with psoriasis may be compromising their health and risking exacerbating their skin condition by seeking ...

This study reveals that dupilumab is associated with a modestly increased risk of developing psoriasis, highlighting the ...

A new consensus from the National Psoriasis Foundation outlines a clear benchmark for remission to improve treatment decisions and patient outcomes.

Vyne Therapeutics has given up hopes of resuming a plaque psoriasis trial for its BET inhibitor placed on hold by the FDA, ...

The autoimmune disease causes raised, scaly patches of skin. As a child, it left the football star embarrassed to remove his ...

Compared with adalimumab, several biologic medications had superior safety profiles for the treatment of moderate to severe psoriasis.

If you feel your psoriasis treatment is not producing what you seek, here are 10 key factors that might be hindering your treatment. Written by: Sushmita Sharma Updated at: Jun 17, 2025 11:01 IST ...

Psoriasis can occur near the eyes, causing redness, itching, dryness, and flaking skin. Once it’s correctly diagnosed, you can often manage it with topical treatments.

Experts defined on-treatment remission for plaque psoriasis as maintaining a BSA of 0% or IGA of 0 for at least 6 months. The standardized benchmarks can be applied in research and practice settings.

Icotrokinra was safe and effective for improving skin clearance among patients with at least moderate psoriasis in ...